Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

WNS Prices Public Offering Of 12.63 Mln ADSs By Warburg Pincus At $12.75/ADS

RELATED NEWS
Trade WNS now with 

WNS (Holdings) Ltd. (WNS: Quote), a provider of global offshore business process outsourcing services, Monday announced the pricing of a previously announced underwritten secondary public offering of 12.63 million ADS's by Warburg Pincus at $12.75 per ADS. The offering is expected to close on or about February 15, 2013.

Also, WNS said that Warburg Pincus granted underwriters a 30-day option to purchase up to an additional 1.9 million ADSs.

WNS in a statement said it shall not receive any proceeds from the sale and added that Warburg Pincus shall have no remaining shareholdings in WNS following the offering, subject to the over-allotment option being exercised in full by the underwriters.

For the offering, BofA Merrill Lynch and Wells Fargo Securities are serving as joint book-running managers, while Baird, William Blair and Janney Montgomery Scott serve as co-managers.

Click here to receive FREE breaking news email alerts for WNS (Holdings) Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After showing a notable move to the upside in early trading on Tuesday, stocks showed a substantial downturn over the course of the session. Concerns about the impact of new sanctions against Russia weighed on the markets. A day after lawmakers announced an agreement on compromise legislation to reform the Veterans Affairs Department, the Senate voted unanimously Tuesday to confirm a new head of the scandal-plagued department. Looking to increase pressure on Congress, the White House released a report on Tuesday warning of the economic costs of delaying action to address climate change.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.